Huakang Biomedical Holdings Company Limited (8622.HK) HKSE

0.41

+0.01(+2.50%)

Updated at December 24 12:08PM

Currency In HKD

Valuation

Market Cap67.97M
Enterprise Value40.56M
P/E Ratio-38.93
PEG Ratio7.09
Price/Sales Ratio7.21
Price/Book Ratio3.55
Enterprise/Revenue6.03
Enterprise/EBITDA-43

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.18
Operating Margin-0.2

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.09

Income Statement

Revenue25.36M
Revenue/Share0.05
Gross Profit17.07M
EBITDA-3.41M
Net Income-4.16M
Diluted EPS-0.01

Balance Sheet

Total Cash36.73M
Total Cash/Share0.07
Total Debt6.42M
Total Debt/Equity0.12
Current Ratio4
Book Value Per Share0.1

Price History

52-Week Change203.7
52-Week High0.75
52-Week Low0.14
Moving Average 50 Days0.48
Moving Average 200 Days0.4

Statistics

Average Volume2.3M
Shares Outstanding503.08M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A